Should Metformin Continue as First-Line Pharmacotherapy for Patients With Type 2 Diabetes? Yes: Metformin Is Still the Best Choice
Am Fam Physician. 2024 Mar;109(3):200-201.NO ABSTRACTPMID:38574204 (Source: American Family Physician)
Source: American Family Physician - April 4, 2024 Category: Primary Care Authors: Gregory Castelli Stacy J Barlett Source Type: research
Conceptual Overview of Prevalence of Prediabetes
Curr Diabetes Rev. 2024 Apr 3. doi: 10.2174/0115733998285294240307052909. Online ahead of print.ABSTRACTPrediabetes increases the risk of type 2 diabetes, metabolic syndrome, chronic renal disease, and cardiovascular disease in a person. In current practice, five alternative definitions of prediabetes are utilized, each based on different HbA1C, fasting glucose, and 2-hour glucose cut points. Prediabetes is a common condition that occurs between normal glycemia and diabetes. It is more common in elderly and obese people. The prevalence of prediabetes and diabetes can be influenced by a variety of individual, family, and so...
Source: Current Diabetes Reviews - April 4, 2024 Category: Endocrinology Authors: None Monika Pragi Arora Varun Kumar Pankaj Popli Source Type: research
Extract mixture of plants (OXYLIA) inhibits fat accumulation by blocking FAS-related factors and promoting lipolysis via cAMP-dependent PKA activation
CONCLUSIONS: These findings suggest that Oxylia has potential as a functional food ingredient for the prevention and treatment of obesity and related metabolic disorders.PMID:38571921 | PMC:PMC10989236 | DOI:10.29219/fnr.v68.10180 (Source: Food and Nutrition Research)
Source: Food and Nutrition Research - April 4, 2024 Category: Nutrition Authors: Seong-Hoo Park Sun-Jung Baek Minhee Lee Hyun-A Shin Hye Jin Lee Ok-Kyung Kim Jeongmin Lee Source Type: research
Extract mixture of plants (OXYLIA) inhibits fat accumulation by blocking FAS-related factors and promoting lipolysis via cAMP-dependent PKA activation
CONCLUSIONS: These findings suggest that Oxylia has potential as a functional food ingredient for the prevention and treatment of obesity and related metabolic disorders.PMID:38571921 | PMC:PMC10989236 | DOI:10.29219/fnr.v68.10180 (Source: Food and Nutrition Research)
Source: Food and Nutrition Research - April 4, 2024 Category: Nutrition Authors: Seong-Hoo Park Sun-Jung Baek Minhee Lee Hyun-A Shin Hye Jin Lee Ok-Kyung Kim Jeongmin Lee Source Type: research
Should Metformin Continue as First-Line Pharmacotherapy for Patients With Type 2 Diabetes? No: Other Drugs Have Stronger Evidence of Benefit
Am Fam Physician. 2024 Mar;109(3):202-203.NO ABSTRACTPMID:38574205 (Source: American Family Physician)
Source: American Family Physician - April 4, 2024 Category: Primary Care Authors: Henry C Barry Allen F Shaughnessy Source Type: research
Should Metformin Continue as First-Line Pharmacotherapy for Patients With Type 2 Diabetes? Yes: Metformin Is Still the Best Choice
Am Fam Physician. 2024 Mar;109(3):200-201.NO ABSTRACTPMID:38574204 (Source: American Family Physician)
Source: American Family Physician - April 4, 2024 Category: Primary Care Authors: Gregory Castelli Stacy J Barlett Source Type: research
Conceptual Overview of Prevalence of Prediabetes
Curr Diabetes Rev. 2024 Apr 3. doi: 10.2174/0115733998285294240307052909. Online ahead of print.ABSTRACTPrediabetes increases the risk of type 2 diabetes, metabolic syndrome, chronic renal disease, and cardiovascular disease in a person. In current practice, five alternative definitions of prediabetes are utilized, each based on different HbA1C, fasting glucose, and 2-hour glucose cut points. Prediabetes is a common condition that occurs between normal glycemia and diabetes. It is more common in elderly and obese people. The prevalence of prediabetes and diabetes can be influenced by a variety of individual, family, and so...
Source: Current Diabetes Reviews - April 4, 2024 Category: Endocrinology Authors: None Monika Pragi Arora Varun Kumar Pankaj Popli Source Type: research
Extract mixture of plants (OXYLIA) inhibits fat accumulation by blocking FAS-related factors and promoting lipolysis via cAMP-dependent PKA activation
CONCLUSIONS: These findings suggest that Oxylia has potential as a functional food ingredient for the prevention and treatment of obesity and related metabolic disorders.PMID:38571921 | PMC:PMC10989236 | DOI:10.29219/fnr.v68.10180 (Source: Food and Nutrition Research)
Source: Food and Nutrition Research - April 4, 2024 Category: Nutrition Authors: Seong-Hoo Park Sun-Jung Baek Minhee Lee Hyun-A Shin Hye Jin Lee Ok-Kyung Kim Jeongmin Lee Source Type: research
Extract mixture of plants (OXYLIA) inhibits fat accumulation by blocking FAS-related factors and promoting lipolysis via cAMP-dependent PKA activation
CONCLUSIONS: These findings suggest that Oxylia has potential as a functional food ingredient for the prevention and treatment of obesity and related metabolic disorders.PMID:38571921 | PMC:PMC10989236 | DOI:10.29219/fnr.v68.10180 (Source: Food and Nutrition Research)
Source: Food and Nutrition Research - April 4, 2024 Category: Nutrition Authors: Seong-Hoo Park Sun-Jung Baek Minhee Lee Hyun-A Shin Hye Jin Lee Ok-Kyung Kim Jeongmin Lee Source Type: research
Should Metformin Continue as First-Line Pharmacotherapy for Patients With Type 2 Diabetes? No: Other Drugs Have Stronger Evidence of Benefit
Am Fam Physician. 2024 Mar;109(3):202-203.NO ABSTRACTPMID:38574205 (Source: American Family Physician)
Source: American Family Physician - April 4, 2024 Category: Primary Care Authors: Henry C Barry Allen F Shaughnessy Source Type: research
Should Metformin Continue as First-Line Pharmacotherapy for Patients With Type 2 Diabetes? Yes: Metformin Is Still the Best Choice
Am Fam Physician. 2024 Mar;109(3):200-201.NO ABSTRACTPMID:38574204 (Source: American Family Physician)
Source: American Family Physician - April 4, 2024 Category: Primary Care Authors: Gregory Castelli Stacy J Barlett Source Type: research
Conceptual Overview of Prevalence of Prediabetes
Curr Diabetes Rev. 2024 Apr 3. doi: 10.2174/0115733998285294240307052909. Online ahead of print.ABSTRACTPrediabetes increases the risk of type 2 diabetes, metabolic syndrome, chronic renal disease, and cardiovascular disease in a person. In current practice, five alternative definitions of prediabetes are utilized, each based on different HbA1C, fasting glucose, and 2-hour glucose cut points. Prediabetes is a common condition that occurs between normal glycemia and diabetes. It is more common in elderly and obese people. The prevalence of prediabetes and diabetes can be influenced by a variety of individual, family, and so...
Source: Current Diabetes Reviews - April 4, 2024 Category: Endocrinology Authors: None Monika Pragi Arora Varun Kumar Pankaj Popli Source Type: research
Extract mixture of plants (OXYLIA) inhibits fat accumulation by blocking FAS-related factors and promoting lipolysis via cAMP-dependent PKA activation
CONCLUSIONS: These findings suggest that Oxylia has potential as a functional food ingredient for the prevention and treatment of obesity and related metabolic disorders.PMID:38571921 | PMC:PMC10989236 | DOI:10.29219/fnr.v68.10180 (Source: Food and Nutrition Research)
Source: Food and Nutrition Research - April 4, 2024 Category: Nutrition Authors: Seong-Hoo Park Sun-Jung Baek Minhee Lee Hyun-A Shin Hye Jin Lee Ok-Kyung Kim Jeongmin Lee Source Type: research
Extract mixture of plants (OXYLIA) inhibits fat accumulation by blocking FAS-related factors and promoting lipolysis via cAMP-dependent PKA activation
CONCLUSIONS: These findings suggest that Oxylia has potential as a functional food ingredient for the prevention and treatment of obesity and related metabolic disorders.PMID:38571921 | PMC:PMC10989236 | DOI:10.29219/fnr.v68.10180 (Source: Food and Nutrition Research)
Source: Food and Nutrition Research - April 4, 2024 Category: Nutrition Authors: Seong-Hoo Park Sun-Jung Baek Minhee Lee Hyun-A Shin Hye Jin Lee Ok-Kyung Kim Jeongmin Lee Source Type: research
Should Metformin Continue as First-Line Pharmacotherapy for Patients With Type 2 Diabetes? No: Other Drugs Have Stronger Evidence of Benefit
Am Fam Physician. 2024 Mar;109(3):202-203.NO ABSTRACTPMID:38574205 (Source: American Family Physician)
Source: American Family Physician - April 4, 2024 Category: Primary Care Authors: Henry C Barry Allen F Shaughnessy Source Type: research
